We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-1.04%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$37.6B
AUM Growth
-$2.31B
(-5.8%)
Cap. Flow
-$309M
Cap. Flow
% of AUM
-0.82%
Top 10 Holdings %
Top 10 Hldgs %
14.09%
Holding
3,035
New
443
Increased
1,011
Reduced
1,232
Closed
320
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$465M |
| 2 |
Amazon
AMZN
|
+$304M |
| 3 |
Apple
AAPL
|
+$297M |
| 4 |
Occidental Petroleum
OXY
|
+$286M |
| 5 |
Zoom
ZM
|
+$259M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coca-Cola
KO
|
+$395M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$373M |
| 3 |
Caterpillar
CAT
|
+$297M |
| 4 |
Intel
INTC
|
+$277M |
| 5 |
NVIDIA
NVDA
|
+$236M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.58% |
| 2 | Healthcare | 20.45% |
| 3 | Consumer Discretionary | 10.84% |
| 4 | Financials | 9.26% |
| 5 | Industrials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Voyager Therapeutics
VYGR
$183M
| $103K | ﹤0.01% |
+13,500
| New | +$60.2K |
|
2502
BBVA Argentina
BBAR
$3.87B
| $102K | ﹤0.01% |
28,700
+12,200
| +74% | +$39.7K |
|
2503
Theravance Biopharma
TBPH
$874M
| $102K | ﹤0.01% |
+10,700
| New | +$105K |
|
|
SQZ
2504
DELISTED
SQZ Biotechnologies Company
SQZ
| $101K | ﹤0.01% |
21,000
+2,400
| +13% | +$15.2K |
|
|
EIGR
2505
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $100K | ﹤0.01% |
400
-715
| -64% | -$113K |
|
2506
Lisata Therapeutics
LSTA
$9.02M
| $99K | ﹤0.01% |
9,173
-6,654
| -42% | -$76.1K |
|
2507
electroCore
ECOR
$54.8M
| $98K | ﹤0.01% |
11,124
-35,102
| -76% | -$318K |
|
2508
Kodak
KODK
$822M
| $98K | ﹤0.01% |
+14,900
| New | +$70.8K |
|
|
KRON
2509
DELISTED
Kronos Bio
KRON
| $98K | ﹤0.01% |
13,500
-7,600
| -36% | -$64.8K |
|
2510
Douglas Elliman
DOUG
$154M
| $97K | ﹤0.01% |
13,965
-113,489
| -89% | -$861K |
|
|
NESR
2511
National Energy Services Reunited Corp
NESR
$2.72B
| $97K | ﹤0.01% |
+11,600
| New | +$110K |
|
2512
Achieve Life Sciences
ACHV
$659M
| $95K | ﹤0.01% |
12,485
-4,770
| -28% | -$35.5K |
|
2513
AC Immune
ACIU
$223M
| $95K | ﹤0.01% |
23,644
-70,200
| -75% | -$304K |
|
|
ASM
2514
Avino Silver & Gold Mines
ASM
$934M
| $94K | ﹤0.01% |
100,100
-4,900
| -5% | -$4.13K |
|
|
AIOS
2515
AIOS Tech
AIOS
$38.4M
| $94K | ﹤0.01% |
+480
| New | +$131K |
|
|
FTH
2516
Faeth Therapeutics
FTH
$702M
| $94K | ﹤0.01% |
2,045
+1,045
| +105% | +$83.2K |
|
|
ME
2517
DELISTED
23andMe Holding Co
ME
| $94K | ﹤0.01% |
+1,225
| New | +$112K |
|
|
HMLP
2518
DELISTED
HOEGH LNG PARTNERS LP
HMLP
| $94K | ﹤0.01% |
+12,700
| New | +$59.1K |
|
2519
Immatics
IMTX
$1.18B
| $90K | ﹤0.01% |
11,300
-300
| -3% | -$2.73K |
|
|
QUMU
2520
DELISTED
Qumu Corp.
QUMU
| $90K | ﹤0.01% |
51,200
-102,800
| -67% | -$192K |
|
|
NXDR
2521
Nextdoor Holdings
NXDR
$847M
| $88K | ﹤0.01% |
+14,700
| New | +$89.5K |
|
|
SURF
2522
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $88K | ﹤0.01% |
30,000
+5,200
| +21% | +$18.2K |
|
|
MMX
2523
DELISTED
Maverix Metals Inc. Common Shares
MMX
| $88K | ﹤0.01% |
18,300
+2,800
| +18% | +$12.9K |
|
2524
Lesaka Technologies
LSAK
$396M
| $87K | ﹤0.01% |
14,800
-4,600
| -24% | -$23.6K |
|
|
MKFG
2525
DELISTED
Markforged Holding Corporation
MKFG
| $87K | ﹤0.01% |
2,180
-540
| -20% | -$23.6K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q1 2022 Portfolio in Review
As of Q1 2022, Two Sigma Advisers held 3,035 positions worth $37.6B, down 5.8% from $39.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Two Sigma Advisers's Q1 2022 filing shows 443 new, 1,011 increased, 1,232 reduced and 320 closed positions. Its largest new stake was PepsiCo: 1,100,300 shares worth $184M. The largest sale was Coca-Cola, an estimated $395M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Two Sigma Advisers's largest Q1 2022 buy was PepsiCo: 1,100,300 shares worth $184M.
- Two Sigma Advisers added most to Adobe in Q1 2022, an estimated $465M increase.
- Two Sigma Advisers's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $395M.
- Two Sigma Advisers fully exited Activision Blizzard in Q1 2022, selling an estimated $373M.
- Two Sigma Advisers's ten largest holdings make up 14% of its $37.6B portfolio in Q1 2022.
- Two Sigma Advisers opened 443 new positions and closed 320 in Q1 2022.
- Two Sigma Advisers's portfolio value fell 5.8% quarter-over-quarter to $37.6B.
Based on Two Sigma Advisers's 13F filing for Q1 2022, filed 16 May 2022.